BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 25675814)

  • 1. [Immune regulation via the generation of extracellular adenosine by CD73].
    Tsukamoto H
    Seikagaku; 2014 Dec; 86(6):766-9. PubMed ID: 25675814
    [No Abstract]   [Full Text] [Related]  

  • 2. Conversion of extracellular ATP into adenosine: a master switch in renal health and disease.
    Dwyer KM; Kishore BK; Robson SC
    Nat Rev Nephrol; 2020 Sep; 16(9):509-524. PubMed ID: 32641760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular ecto-5'-nucleotidase: an end to 40 years in the wilderness?
    Olsson RA
    Circ Res; 2004 Oct; 95(8):752-3. PubMed ID: 15486321
    [No Abstract]   [Full Text] [Related]  

  • 4. Generation and Function of Non-cell-bound CD73 in Inflammation.
    Schneider E; Rissiek A; Winzer R; Puig B; Rissiek B; Haag F; Mittrücker HW; Magnus T; Tolosa E
    Front Immunol; 2019; 10():1729. PubMed ID: 31404305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting the CD73-adenosine axis in immuno-oncology.
    Allard D; Chrobak P; Allard B; Messaoudi N; Stagg J
    Immunol Lett; 2019 Jan; 205():31-39. PubMed ID: 29758241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted disruption of cd73/ecto-5'-nucleotidase alters thromboregulation and augments vascular inflammatory response.
    Koszalka P; Ozüyaman B; Huo Y; Zernecke A; Flögel U; Braun N; Buchheiser A; Decking UK; Smith ML; Sévigny J; Gear A; Weber AA; Molojavyi A; Ding Z; Weber C; Ley K; Zimmermann H; Gödecke A; Schrader J
    Circ Res; 2004 Oct; 95(8):814-21. PubMed ID: 15358667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD73 and adenosine generation in the creation of regulatory microenvironments.
    Regateiro FS; Cobbold SP; Waldmann H
    Clin Exp Immunol; 2013 Jan; 171(1):1-7. PubMed ID: 23199317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological blockade of the CD39/CD73 pathway but not adenosine receptors augments disease in a humanized mouse model of graft-versus-host disease.
    Geraghty NJ; Watson D; Sluyter R
    Immunol Cell Biol; 2019 Jul; 97(6):597-610. PubMed ID: 30957314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer exosomes express CD39 and CD73, which suppress T cells through adenosine production.
    Clayton A; Al-Taei S; Webber J; Mason MD; Tabi Z
    J Immunol; 2011 Jul; 187(2):676-83. PubMed ID: 21677139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenosine Formed by CD73 on T Cells Inhibits Cardiac Inflammation and Fibrosis and Preserves Contractile Function in Transverse Aortic Constriction-Induced Heart Failure.
    Quast C; Alter C; Ding Z; Borg N; Schrader J
    Circ Heart Fail; 2017 Apr; 10(4):. PubMed ID: 28404626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enzyme activity of circulating CD73 in human serum.
    Morello S; Turiello R; Madonna G; Pinto A; Ascierto PA; Capone M
    Methods Enzymol; 2019; 629():257-267. PubMed ID: 31727244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of CD39 enzymatic function at the surface of tumor cells alleviates their immunosuppressive activity.
    Bastid J; Regairaz A; Bonnefoy N; Déjou C; Giustiniani J; Laheurte C; Cochaud S; Laprevotte E; Funck-Brentano E; Hemon P; Gros L; Bec N; Larroque C; Alberici G; Bensussan A; Eliaou JF
    Cancer Immunol Res; 2015 Mar; 3(3):254-65. PubMed ID: 25403716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ecto-5'-nucleotidase/CD73 enhances endothelial barrier function and sprouting in blood but not lymphatic vasculature.
    Yegutkin GG; Auvinen K; Rantakari P; Hollmén M; Karikoski M; Grénman R; Elima K; Jalkanen S; Salmi M
    Eur J Immunol; 2015 Feb; 45(2):562-73. PubMed ID: 25402681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD73 Controls Extracellular Adenosine Generation in the Trigeminal Nociceptive Nerves.
    Liu X; Ma L; Zhang S; Ren Y; Dirksen RT
    J Dent Res; 2017 Jun; 96(6):671-677. PubMed ID: 28530470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measurement of CD73 enzymatic activity using luminescence-based and colorimetric assays.
    Allard B; Cousineau I; Spring K; Stagg J
    Methods Enzymol; 2019; 629():269-289. PubMed ID: 31727245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IFN-alpha induced adenosine production on the endothelium: a mechanism mediated by CD73 (ecto-5'-nucleotidase) up-regulation.
    Niemelä J; Henttinen T; Yegutkin GG; Airas L; Kujari AM; Rajala P; Jalkanen S
    J Immunol; 2004 Feb; 172(3):1646-53. PubMed ID: 14734746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression.
    Deaglio S; Dwyer KM; Gao W; Friedman D; Usheva A; Erat A; Chen JF; Enjyoji K; Linden J; Oukka M; Kuchroo VK; Strom TB; Robson SC
    J Exp Med; 2007 Jun; 204(6):1257-65. PubMed ID: 17502665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ecto-5' nucleotidase (CD73)-mediated adenosine generation and signaling in murine cardiac allograft vasculopathy.
    Hasegawa T; Bouïs D; Liao H; Visovatti SH; Pinsky DJ
    Circ Res; 2008 Dec; 103(12):1410-21. PubMed ID: 19008478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenosine and hypoxia-inducible factor signaling in intestinal injury and recovery.
    Colgan SP; Eltzschig HK
    Annu Rev Physiol; 2012; 74():153-75. PubMed ID: 21942704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Control of adenosine transport by hypoxia.
    Görlach A
    Circ Res; 2005 Jul; 97(1):1-3. PubMed ID: 16002753
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.